Benjamin J. Thompson

1.8k total citations
22 papers, 1.3k citations indexed

About

Benjamin J. Thompson is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Benjamin J. Thompson has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Benjamin J. Thompson's work include Proteoglycans and glycosaminoglycans research (4 papers), Fibroblast Growth Factor Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Benjamin J. Thompson is often cited by papers focused on Proteoglycans and glycosaminoglycans research (4 papers), Fibroblast Growth Factor Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Benjamin J. Thompson collaborates with scholars based in United States, United Kingdom and France. Benjamin J. Thompson's co-authors include Iannis Aifantis, Silvia Buonamici, Teresa Palomero, Adolfo A. Ferrando, Tomas Vilimas, Giuseppe Basso, Maria Luisa Sulis, Jiří Zavadil, John D. Crispino and Lauren Diebold and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Benjamin J. Thompson

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin J. Thompson United States	11	901	301	262	227	222	22	1.3k
Tim Lammens Belgium	23	1.3k 1.4×	136 0.5×	262 1.0×	232 1.0×	194 0.9×	64	1.9k
Annahita Sallmyr United States	13	957 1.1×	296 1.0×	276 1.1×	84 0.4×	143 0.6×	26	1.3k
Manabu Inuzuka Japan	13	1.1k 1.3×	545 1.8×	341 1.3×	99 0.4×	224 1.0×	24	1.5k
Amit Grover India	16	718 0.8×	554 1.8×	136 0.5×	111 0.5×	528 2.4×	32	1.5k
Barbara E. Crute United States	13	1.0k 1.2×	403 1.3×	180 0.7×	85 0.4×	200 0.9×	15	1.4k
Laurent Pérès France	15	1.6k 1.7×	673 2.2×	271 1.0×	104 0.5×	192 0.9×	19	1.7k
Alison A. Bertuch United States	27	1.4k 1.6×	343 1.1×	209 0.8×	81 0.4×	206 0.9×	77	2.2k
Éric Milot Canada	21	1.2k 1.3×	163 0.5×	161 0.6×	91 0.4×	240 1.1×	35	1.6k
H Hirai Japan	16	596 0.7×	321 1.1×	332 1.3×	72 0.3×	227 1.0×	36	1.1k
Andrew J.K. Williamson United Kingdom	18	660 0.7×	213 0.7×	169 0.6×	44 0.2×	125 0.6×	35	1.0k

Countries citing papers authored by Benjamin J. Thompson

Since Specialization

Citations

This map shows the geographic impact of Benjamin J. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Thompson more than expected).

Fields of papers citing papers by Benjamin J. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Thompson. The network helps show where Benjamin J. Thompson may publish in the future.

Co-authorship network of co-authors of Benjamin J. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Thompson. A scholar is included among the top collaborators of Benjamin J. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Thompson. Benjamin J. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bupathi, Manojkumar, Siwen Hu‐Lieskovan, Sarina A. Piha‐Paul, et al.. (2023). 764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A859–A859. 3 indexed citations

Akce, Mehmet, Siwen Hu‐Lieskovan, Matthew J. Reilley, et al.. (2022). A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3).. Journal of Clinical Oncology. 40(16_suppl). 2604–2604. 8 indexed citations

Zhao, Chun‐Mei, Benjamin J. Thompson, Kelly Chen, et al.. (2019). The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44. Oncotarget. 10(61). 6561–6576. 7 indexed citations

Thompson, Benjamin J., Darin Taverna, Barbara Blouw, et al.. (2018). Abstract 1743: Rationale for evaluating PEGylated recombinant human hyaluronidase PH20 (pegvorhyaluronidase alfa; PEGPH20) in patients with hyaluronan (HA)-accumulating colorectal cancer. Cancer Research. 78(13_Supplement). 1743–1743. 1 indexed citations

Thompson, Benjamin J., et al.. (2018). PO-262 Remodelling of the tumour microenvironment by pegvorhyalurondiase alfa (PEGPH20): a novel, first-in-class biologic that enzymatically degrades tumour hyaluronan (HA) to improve anti-tumour efficacy. ESMO Open. 3. A329–A330.

Thompson, Benjamin J., Barbara Blouw, Yujun Huang, et al.. (2018). Abstract B38: Increasing tumor-infiltrating CD8+ T cell response and checkpoint inhibitor efficacy by enzymatic reduction of tumor hyaluronan in a murine syngeneic pancreatic cancer model. Cancer Immunology Research. 6(9_Supplement). B38–B38. 2 indexed citations

Ansó, Elena, Samuel E. Weinberg, Lauren Diebold, et al.. (2017). The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nature Cell Biology. 19(6). 614–625. 221 indexed citations

Rosengren, Sanna, Benjamin J. Thompson, Barbara Blouw, et al.. (2016). Abstract 4886: PEGylated recombinant hyaluronidase PH20 (PEGPH20) enhances checkpoint inhibitor efficacy in syngeneic mouse models of cancer. Cancer Research. 76(14_Supplement). 4886–4886. 8 indexed citations

Thompson, Benjamin J., Rahul S. Bhansali, Lauren Diebold, et al.. (2015). DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3. The Journal of Experimental Medicine. 212(6). 953–970. 50 indexed citations

10.

Thompson, Benjamin J., Lauren Diebold, Sébastien Malinge, et al.. (2013). The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia. Blood. 122(21). 814–814. 1 indexed citations

11.

Widdick, David A., Matthew G. Hicks, Benjamin J. Thompson, et al.. (2011). Dissecting the complete lipoprotein biogenesis pathway in Streptomyces scabies. Molecular Microbiology. 80(5). 1395–1412. 38 indexed citations

12.

Thompson, Benjamin J., David A. Widdick, Matthew G. Hicks, et al.. (2010). Investigating lipoprotein biogenesis and function in the model Gram‐positive bacterium Streptomyces coelicolor. Molecular Microbiology. 77(4). 943–957. 54 indexed citations

13.

Reavie, Linsey B., Giusy Della Gatta, Beatriz Aranda-Orgillés, et al.. (2010). Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex. Nature Immunology. 11(3). 207–215. 97 indexed citations

14.

Thompson, Benjamin J., Vladimir Janković, Jie Gao, et al.. (2008). Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. The Journal of Experimental Medicine. 205(6). 1395–1408. 145 indexed citations

15.

Thompson, Benjamin J., Vladimir Janković, Jie Gao, et al.. (2008). Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. The Journal of Cell Biology. 181(4). i16–i16. 2 indexed citations

16.

Thompson, Benjamin J., Silvia Buonamici, Maria Luisa Sulis, et al.. (2007). The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. The Journal of Experimental Medicine. 204(8). 1825–1835. 363 indexed citations

17.

Vilimas, Tomas, Joaquina Mascarenhas, Teresa Palomero, et al.. (2006). Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nature Medicine. 13(1). 70–77. 261 indexed citations

18.

Morgan, Adam J., Kimberly A. Stieglitz, Boguslaw Stec, et al.. (2006). The Temperature Dependence of the Inositol Monophosphatase K_m Correlates with Accumulation of Di-myo-inositol 1,1‘-Phosphate in Archaeoglobus fulgidus. Biochemistry. 45(10). 3307–3314. 18 indexed citations

19.

Franceschetti, Marina, Barry Perry, Benjamin J. Thompson, Colin Hanfrey, & Anthony J. Michael. (2004). Expression proteomics identifies biochemical adaptations and defense responses in transgenic plants with perturbed polyamine metabolism. FEBS Letters. 576(3). 477–480. 9 indexed citations

20.

Hutchings, Matthew I., Jason C. Crack, Neil Shearer, et al.. (2002). Transcription Factor FnrP from Paracoccus denitrificans Contains an Iron-Sulfur Cluster and Is Activated by Anoxia: Identification of Essential Cysteine Residues. Journal of Bacteriology. 184(2). 503–508. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact